S&P 500   4,267.52
DOW   33,665.02
QQQ   348.82
Stock market today: Asian shares slip following technology selloff on Wall Street
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Tesla: How and Why It Gets To $300
Don't Overlook Hidden Gem Kinsale As Rallies To New Highs
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
AI-powered IoT Automation is Driving Samsara To New Highs
What is a Growth Stock Mutual Fund?
Laser breakthrough could send stock soaring 2,467% (Ad)
Persistent inflation, higher interest rates will weigh on global economy, OECD predicts
Sprinklr Gets Targets Raised By Analysts, Here's Why
S&P 500   4,267.52
DOW   33,665.02
QQQ   348.82
Stock market today: Asian shares slip following technology selloff on Wall Street
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Tesla: How and Why It Gets To $300
Don't Overlook Hidden Gem Kinsale As Rallies To New Highs
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
AI-powered IoT Automation is Driving Samsara To New Highs
What is a Growth Stock Mutual Fund?
Laser breakthrough could send stock soaring 2,467% (Ad)
Persistent inflation, higher interest rates will weigh on global economy, OECD predicts
Sprinklr Gets Targets Raised By Analysts, Here's Why
S&P 500   4,267.52
DOW   33,665.02
QQQ   348.82
Stock market today: Asian shares slip following technology selloff on Wall Street
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Tesla: How and Why It Gets To $300
Don't Overlook Hidden Gem Kinsale As Rallies To New Highs
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
AI-powered IoT Automation is Driving Samsara To New Highs
What is a Growth Stock Mutual Fund?
Laser breakthrough could send stock soaring 2,467% (Ad)
Persistent inflation, higher interest rates will weigh on global economy, OECD predicts
Sprinklr Gets Targets Raised By Analysts, Here's Why
S&P 500   4,267.52
DOW   33,665.02
QQQ   348.82
Stock market today: Asian shares slip following technology selloff on Wall Street
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Tesla: How and Why It Gets To $300
Don't Overlook Hidden Gem Kinsale As Rallies To New Highs
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
AI-powered IoT Automation is Driving Samsara To New Highs
What is a Growth Stock Mutual Fund?
Laser breakthrough could send stock soaring 2,467% (Ad)
Persistent inflation, higher interest rates will weigh on global economy, OECD predicts
Sprinklr Gets Targets Raised By Analysts, Here's Why

Syneos Health (SYNH) Stock Forecast, Price & News

$41.75
+0.22 (+0.53%)
(As of 06/7/2023 ET)
Compare
Today's Range
$41.51
$41.83
50-Day Range
$34.50
$41.85
52-Week Range
$22.89
$79.77
Volume
4.14 million shs
Average Volume
2.27 million shs
Market Capitalization
$4.33 billion
P/E Ratio
29.20
Dividend Yield
N/A
Price Target
$47.63

Syneos Health MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
14.1% Upside
$47.63 Price Target
Short Interest
Healthy
2.57% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.00
Upright™ Environmental Score
News Sentiment
0.78mentions of Syneos Health in the last 14 days
Based on 5 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
25.35%
From $2.84 to $3.56 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.56 out of 5 stars

Medical Sector

107th out of 981 stocks

Commercial Physical Research Industry

2nd out of 13 stocks


SYNH stock logo

About Syneos Health (NASDAQ:SYNH) Stock

Syneos Health, Inc., operates as an integrated biopharmaceutical solutions company. The company operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics in Phase I to IV of clinical development. This segment offers individual services, including regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health services, clinical trial diversity, biometrics, and regulatory affairs. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions, such as public relations, advertising, and medical communication; and consulting services. Its customers include companies in the biopharmaceutical, biotechnology, and medical device industries. It operates in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. The company was formerly known as INC Research Holdings, Inc. and changed its name to Syneos Health, Inc. in January 2018. Syneos Health, Inc. was incorporated in 2010 and is headquartered in Morrisville, North Carolina.

Receive SYNH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Syneos Health and its competitors with MarketBeat's FREE daily newsletter.

SYNH Stock News Headlines

66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
Laser breakthrough could send stock soaring 2,467%
Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...
8 Analysts Have This to Say About Syneos Health
Syneos Health (NASDAQ:SYNH) Sees Large Volume Increase
Syneos Health (NASDAQ:SYNH) Shares Gap Up to $38.45
Robert W. Baird downgrades Syneos Health (SYNH) to a Hold
See More Headlines

SYNH Price History

SYNH Company Calendar

Last Earnings
11/03/2021
Today
6/07/2023
Next Earnings (Estimated)
8/01/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Commercial physical research
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SYNH
Employees
29,395
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$47.63
High Stock Price Forecast
$73.00
Low Stock Price Forecast
$28.00
Forecasted Upside/Downside
+14.1%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
9 Analysts

Profitability

Net Income
$266.50 million
Pretax Margin
3.43%

Debt

Sales & Book Value

Annual Sales
$5.39 billion
Cash Flow
$6.74 per share
Book Value
$33.96 per share

Miscellaneous

Free Float
103,295,000
Market Cap
$4.33 billion
Optionable
Optionable
Beta
1.61

Key Executives

  • Ms. Michelle  KeefeMs. Michelle Keefe (Age 56)
    CEO & Director
    Comp: $876.28k
  • Mr. Michael Lee BrooksMr. Michael Lee Brooks (Age 49)
    Chief Operating Officer
    Comp: $702.11k
  • Mr. Jonathan  Olefson Esq.Mr. Jonathan Olefson Esq. (Age 47)
    Gen. Counsel, Corp. Sec. & Interim Chief HR Officer
    Comp: $526.13k
  • Mr. Christian Tucat MBA (Age 53)
    Chief Bus. Officer
    Comp: $517.29k
  • Mr. Jason M. MeggsMr. Jason M. Meggs (Age 47)
    Consultant
    Comp: $624.83k
  • Mr. Stanford Rudnick (Age 39)
    Interim Chief Financial Officer
  • Ms. Donna Hildebrand KralowetzMs. Donna Hildebrand Kralowetz (Age 52)
    Sr. VP of Fin. & Chief Accounting Officer
  • Mr. Baba Shetty
    Pres of Technology & Data Solutions
  • Dr. Judith Ng-Cashin M.D. (Age 54)
    Chief Scientific Officer
  • Mr. Larry A. Pickett Jr.
    Chief Information & Digital Officer













SYNH Stock - Frequently Asked Questions

Should I buy or sell Syneos Health stock right now?

9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Syneos Health in the last year. There are currently 9 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" SYNH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SYNH, but not buy additional shares or sell existing shares.
View SYNH analyst ratings
or view top-rated stocks.

What is Syneos Health's stock price forecast for 2023?

9 Wall Street analysts have issued 12-month price targets for Syneos Health's stock. Their SYNH share price forecasts range from $28.00 to $73.00. On average, they expect the company's share price to reach $47.63 in the next twelve months. This suggests a possible upside of 14.1% from the stock's current price.
View analysts price targets for SYNH
or view top-rated stocks among Wall Street analysts.

How have SYNH shares performed in 2023?

Syneos Health's stock was trading at $36.68 on January 1st, 2023. Since then, SYNH stock has increased by 13.8% and is now trading at $41.75.
View the best growth stocks for 2023 here
.

When is Syneos Health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 1st 2023.
View our SYNH earnings forecast
.

How were Syneos Health's earnings last quarter?

Syneos Health, Inc. (NASDAQ:SYNH) posted its quarterly earnings results on Wednesday, November, 3rd. The company reported $1.22 EPS for the quarter, beating the consensus estimate of $1.17 by $0.05. The business earned $1.35 billion during the quarter, compared to the consensus estimate of $1.34 billion. Syneos Health had a trailing twelve-month return on equity of 12.14% and a net margin of 2.74%. Syneos Health's quarterly revenue was up 22.7% compared to the same quarter last year. During the same period in the prior year, the business earned $0.93 earnings per share.

What is Alistair Macdonald's approval rating as Syneos Health's CEO?

322 employees have rated Syneos Health Chief Executive Officer Alistair Macdonald on Glassdoor.com. Alistair Macdonald has an approval rating of 82% among the company's employees.

What other stocks do shareholders of Syneos Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Syneos Health investors own include NVIDIA (NVDA), Pfizer (PFE), Block (SQ), Advanced Micro Devices (AMD), Boeing (BA), Alibaba Group (BABA), ICON Public (ICLR), Netflix (NFLX), AbbVie (ABBV) and Intel (INTC).

What is Syneos Health's stock symbol?

Syneos Health trades on the NASDAQ under the ticker symbol "SYNH."

Who are Syneos Health's major shareholders?

Syneos Health's stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (10.18%), Wellington Management Group LLP (7.27%), Clearbridge Investments LLC (4.02%), Barclays PLC (2.96%), State Street Corp (2.75%) and FMR LLC (2.68%). Insiders that own company stock include Alistair Macdonald, Donna Hildebrand Kralowetz, International Corp/Ma Advent, Jason M Meggs, John L Maldonado, John M Dineen, Jonathan Olefson, Linda S Harty, Mark E Jagiela, Matthew E Monaghan, Matthew E Monaghan, Michael Lee Brooks, Michelle Keefe, Thomas H Lee Advisors, Llc and Tom Allen.
View institutional ownership trends
.

How do I buy shares of Syneos Health?

Shares of SYNH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Syneos Health's stock price today?

One share of SYNH stock can currently be purchased for approximately $41.75.

How much money does Syneos Health make?

Syneos Health (NASDAQ:SYNH) has a market capitalization of $4.33 billion and generates $5.39 billion in revenue each year. The company earns $266.50 million in net income (profit) each year or $1.43 on an earnings per share basis.

How many employees does Syneos Health have?

The company employs 29,395 workers across the globe.

How can I contact Syneos Health?

Syneos Health's mailing address is 1030 Sync Street, Morrisville NC, 27560. The official website for the company is www.syneoshealth.com. The company can be reached via phone at (919) 876-9300, via email at investor.relations@syneoshealth.com, or via fax at 919-876-9360.

This page (NASDAQ:SYNH) was last updated on 6/8/2023 by MarketBeat.com Staff

My Account -